MedPath

Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution

Conditions
COVID-19
Breast Cancer
Registration Number
NCT04750018
Lead Sponsor
Chen-Pin Chou
Brief Summary

To assess whether the COVID-19 pandemic delayed breast cancer diagnosis in Taiwan, an Asian country with a low COVID-19 incidence.

Detailed Description

The institutional review board approved this retrospective study at a public academic medical center. The monthly volume of breast biopsies and breast cancers during the COVID-19 pandemic (between January 1 and July 31, 2020) was compared to the same period a year earlier (pre-COVID-19).

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
600
Inclusion Criteria
  • Receiving breast exam 2019-2020
Exclusion Criteria
  • lost clinical follow-up

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
breast cancer1 year

Breast cancer or not

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Radiology depart

🇨🇳

Kaohsiung, Taiwan

Radiology depart
🇨🇳Kaohsiung, Taiwan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.